50 days to first decision for reviewed manuscripts only
32 days to first decision for all manuscripts
72 days from submission to acceptance
12 days from acceptance to publication
MicroRNA-143 targets MAPK3 to regulate the proliferation and bone metastasis of human breast cancer cells
MicroRNAs (miRs) have shown tremendous potential to act as therapeutic targets for cancer treatment. In this context, the present study was designed to investigate the potential of miR-143 in the treatment of...
Citation: AMB Express 2020 10:134